COMPANY OVERVIEW

Neurimmune is a biopharmaceutical company dedicated to the development of unique classes of human therapeutic antibodies for the treatment and prevention of important human diseases with a high unmet medical need.

---

LOCATION

Schlieren, , Switzerland

---

THERAPEUTIC AREAS

Metabolic Disorders

Neurological DIsorders

Oncology

Rare Diseases

---

WEBSITE

https://www.neurimmune.com/

---

CAREER WEBSITE

https://www.neurimmune.com/careers/working-at-neurimmune.html

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jan 17, 2022

Neurimmune expands drug discovery collaboration with Ono Pharmaceutical in the field of neurodegenerative diseases

Jan 7, 2022

Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006

Nov 18, 2021

Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma's Phase 2 Study of AP-101 for the Treatment of ALS

Apr 1, 2020

Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of COVID-19

Feb 27, 2020

Neurimmune Announces the Initiation of a Phase 1 Study of NI006 for the Treatment of ATTR Cardiomyopathy

For More Press Releases

---